Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Test-retest Study to Evaluate the Reproducibility of [18F]Florbetaben PET Imaging in Patients With Cardiac Amyloidosis and Control Patients

NCT06790394 is registered in ClinicalTrials.gov with Lantheus Germany GmbH as lead sponsor.

NCT NCT06790394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06790394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Test-retest Study to Evaluate the Reproducibility of [18F]Florbetaben PET Imaging in Patients With Cardiac Amyloidosis and Control Patients
Lead sponsor
Lantheus Germany GmbH
Phase
Phase 1
Overall status
Recruiting
Start date
October 21, 2025
Completion date
September 30, 2026
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac amyloidosis